Location History:
- Rehovot, IL (2011)
- Kiryat Ekron, IL (2011 - 2013)
Company Filing History:
Years Active: 2011-2025
Title: Arthur Machlenkin: Innovator in Anti-Viral and Anti-Tumoral Compounds
Introduction
Arthur Machlenkin is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target viral and tumoral diseases. With a total of 4 patents to his name, Machlenkin's work is at the forefront of medical innovation.
Latest Patents
Among his latest patents, Machlenkin has developed anti-viral and anti-tumoral compounds. These compounds include 3,4-didehydro- and 3'-deoxy-3,4-didehydro-compounds, along with pharmaceutical compositions designed to treat various diseases. The methods of use for these compositions encompass treatments for virus-induced diseases, cancer, autoimmune diseases, immune disorders, and bacterial-associated infections. Notably, his research addresses viral infections caused by RNA or DNA viruses, including SAR-CoV-2, EBV, BKV, JCV, and HCMV.
Another significant patent involves methods and immunogenic cell preparations for treating antigen-associated diseases. This method focuses on inhibiting the growth of specific cell populations in subjects by thermally, mechanically, or chemically damaging antigen-bearing cells. The process generates immunogenic cells that, when introduced into the subject, can induce an immune response to combat the targeted cell population.
Career Highlights
Machlenkin's career is marked by his innovative research and development efforts at Yeda Research and Development Co. Ltd. His work has not only advanced scientific understanding but has also paved the way for new therapeutic approaches in medicine.
Collaborations
Some of his notable coworkers include Lea Eisenbach and Boaz Tirosh, who have collaborated with him on various projects, contributing to the success of their research endeavors.
Conclusion
Arthur Machlenkin stands out as a key figure in the development of anti-viral and anti-tumoral compounds. His innovative patents and contributions to medical science highlight the importance of research in combating serious health challenges.